Concepedia

Trends in prevention of glucocorticoid-induced osteoporosis.

Kenneth G. Saag, Stephen H. Gehlbach, Jeffrey R. Curtis, Thomas E. Youket, Karen Worley, Jeffrey L. Lange

PubMed · 2006 · 59 citations · 17 references

Abstract

Among patients initiating longterm glucocorticoid therapy, the proportion of individuals receiving a bone mass measurement or anti-osteoporotic medication remains relatively low, but has improved temporally among postmenopausal women.

References

17

Applied Logistic Regression Analysis

Technometrics · 1996 · 3.6K citations

Logistic Regression 6, Series Editor, Second Edition 1 +10

Use of oral corticosteroids in the United Kingdom

Tjeerd van Staa · QJM · 2000 · 530 citations · Full text

Scientific Advisory Council of the Osteoporosis Society of Canada : 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

Jacques P. Brown · Canadian Medical Association Journal · 2002 · 294 citations · Full text

Bone Disease, Bone Health, Osteopathy +8

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update

Yasuo Suzuki, Hajime Nawata, Satoshi Soen et al. · Journal of Bone and Mineral Metabolism · 2014 · 289 citations

Japanese Society, Bone Disease, Bone Health +6

Oral glucocorticoid use is associated with an increased risk of fracture

Michael Steinbuch, Thomas E. Youket, Stanley Cohen · Osteoporosis International · 2004 · 275 citations

Skeletal Trauma, Bone Disease, Bone Health +5